SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/948171C5CB4EDE66FACEDC0D0B69E6147E19DC114211758605DF53FB1A8D208D586DF7E28AB7A3114888CDBFF55DC1E3>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/948171C5CB4EDE66FACEDC0D0B69E6147E19DC114211758605DF53FB1A8D208D586DF7E28AB7A3114888CDBFF55DC1E3
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/948171C5CB4EDE66FACEDC0D0B69E6147E19DC114211758605DF53FB1A8D208D586DF7E28AB7A3114888CDBFF55DC1E3
http://www.w3.org/2000/01/rdf-schema#comment
"Sulfonylthiadiazoles with an unusual binding mode were shown as partial dual peroxisome proliferator-activated receptor (PPAR) gamma/delta agonists with high potency and in vivo efficacy."
xsd:string
http://purl.uniprot.org/uniprot/#_D6934DCF093D12666F54463806F9BFDC95E9E09A755845C4F2C9999B8AA61B8E7378B9D6EB42D9B63DE6E7C1B7356522
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/948171C5CB4EDE66FACEDC0D0B69E6147E19DC114211758605DF53FB1A8D208D586DF7E28AB7A3114888CDBFF55DC1E3
http://purl.uniprot.org/uniprot/Q6RI63
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/948171C5CB4EDE66FACEDC0D0B69E6147E19DC114211758605DF53FB1A8D208D586DF7E28AB7A3114888CDBFF55DC1E3
http://purl.uniprot.org/uniprot/#_Q6RI63-mappedCitation-21400663
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/948171C5CB4EDE66FACEDC0D0B69E6147E19DC114211758605DF53FB1A8D208D586DF7E28AB7A3114888CDBFF55DC1E3